| Novel SUMO-protease SENP7S regulates β-catenin signaling and mammary epithelial cell transformation S Karami, FM Lin, S Kumar, S Bahnassy, H Thangavel, M Quttina, Y Li, ... Scientific reports 7 (1), 46477, 2017 | 27 | 2017 |
| The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation … M Faria, S Karami, S Granados-Principal, P Dey, A Verma, DS Choi, ... Oncotarget 9 (15), 12201, 2018 | 17 | 2018 |
| SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy FM Lin, S Kumar, J Ren, S Karami, S Bahnassy, Y Li, X Zheng, J Wang, ... Oncotarget 7 (21), 30336, 2016 | 17 | 2016 |
| Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer S Bahnassy, H Thangavel, M Quttina, AF Khan, D Dhanyalayam, J Ritho, ... Cell Communication and Signaling 18, 1-11, 2020 | 16 | 2020 |
| Abstract P3-04-21: Androgen receptor in tamoxifen-resistant breast cancer is affected by SUMO S Bahnassy, S Kumar, J Ren, G Frutiz, S Karami, T Bawa-Khalfe Cancer Research 77 (4_Supplement), P3-04-21-P3-04-21, 2017 | 1 | 2017 |
| lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer KD Waiters, M Quttina, AF Khan, S Karami, AS Peidl, F Babajide, ... Cancer Research 84 (6_Supplement), 5683-5683, 2024 | | 2024 |
| Abstract A023: lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer KD Waiters, M Quttina, AF Khan, S Karami, A Peidl, F Babajide, ... Cancer Research 84 (3_Supplement_1), A023-A023, 2024 | | 2024 |
| Androgen Receptor in Hormone Receptor-Positive Breast Cancer AF Khan, S Karami, AS Peidl, KD Waiters, MF Babajide, T Bawa-Khalfe International Journal of Molecular Sciences 25 (1), 476, 2023 | | 2023 |
| Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer M Quttina, KD Waiters, AF Khan, S Karami, AS Peidl, MF Babajide, ... Cells 12 (20), 2495, 2023 | | 2023 |
| Impact of SUMO Post-translational Modification on Breast Cancer Development F Babajide, S Karami, K Waiters, A Peidl | | 2023 |
| Abstract PS17-33: Sumo-modified androgen receptors support the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer T Bawa-Khalfe, S Bahnassy, H Thangavel, M Quttina, AF Khan, ... Cancer Research 81 (4_Supplement), PS17-33-PS17-33, 2021 | | 2021 |
| Sumo-modified androgen receptors support the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer T Bawa-Khalfe, S Bahnassy, H Thangavel, M Quttina, AF Khan, ... CANCER RESEARCH 81 (4), 2021 | | 2021 |
| New dual-targeting approach for combating hormone receptor-positive breast cancer S Bahnassy, H Thangavel, M Quttina, A Khan, D Dhanyalayam, J Ritho, ... | | 2020 |
| Abstract P6-07-10: The ERβ4 variant induce transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2, ERβ4 and ERβ5 increase … M Faria, S Karami, S Granados-Principal, P Dey, A Verma, DS Choi, ... Cancer Research 78 (4_Supplement), P6-07-10-P6-07-10, 2018 | | 2018 |
| Abstract P1-04-08: Non-nuclear SUMO dynamics regulate mammary epithelial cell transformation S Karami, FM Lin, S Kumar, J Ren, S Bahnassy, T Bawa-Khalfe Cancer Research 77 (4_Supplement), P1-04-08-P1-04-08, 2017 | | 2017 |
